Replies to post #223187 on NorthWest Biotherapeutics Inc (NWBO)

[JRIII]

CherryTree1, I've read that transcript many times and I agree that Linda never said they would present anything at ASCO. In fact, her words were precisely why I posted the abstract comment. Please, before responding, try to read what I write a little more carefully. My post was not directed at Linda; it was directed at the pumpers on this message board who have been telling us we are going to get topline at ASCO. They've been writing this nonsense for months, and they've been writing it despite what Linda said at the ASM, which I took as a pretty clear lowering of expectations on her part. No, I agree we aren't going to get anything at ASCO and Linda pretty much confirmed it at the ASM.

[Sojourner55]

CherryTree, you can't book the Industry Theatre on short notice so this was planned way in advance despite what Linda says

"ASCO is certainly a great venue and it's been great for us when the timing has worked out, to be able to, as we did last year we had just announced the first interim data from our phase III trial, three days before ASCO, that just happened to work out beautifully on the timing. "

They assembled the patient stories to be present and this take logistical planning months ahead.

So was 2017.

I suspect the same this year.

[martyDg]

maybe a stupid question for you but whatever...

Does visiting of 82 sites included to complete the SAP or it's another procedure to towards unblinding?

Do you know how many CRA they get to physically visits 82 sites? and how long do you think will take to finish the visitation?

TIA